Accuray Incorporated (ARAY)
USD 1.51
(3.42%)
USD 1.51
(3.42%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 423.54 Million USD | -0.47% |
| 2023 | 425.55 Million USD | 1.4% |
| 2022 | 419.66 Million USD | 2.04% |
| 2021 | 411.25 Million USD | -3.75% |
| 2020 | 427.29 Million USD | 10.04% |
| 2019 | 388.31 Million USD | 17.64% |
| 2018 | 330.09 Million USD | -8.29% |
| 2017 | 359.93 Million USD | -12.08% |
| 2016 | 409.37 Million USD | 3.85% |
| 2015 | 394.19 Million USD | -0.62% |
| 2014 | 396.64 Million USD | 7.46% |
| 2013 | 369.09 Million USD | 37.06% |
| 2012 | 269.3 Million USD | 24.99% |
| 2011 | 215.45 Million USD | 131.41% |
| 2010 | 93.1 Million USD | -22.72% |
| 2009 | 120.48 Million USD | -26.64% |
| 2008 | 164.24 Million USD | -20.53% |
| 2007 | 206.66 Million USD | -5.84% |
| 2006 | 219.47 Million USD | 53.45% |
| 2005 | 143.03 Million USD | 0.0% |
| 2003 | 65.39 Million USD | 83.92% |
| 2002 | 35.55 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 423.54 Million USD | -0.47% |
| 2024 Q2 | 428.69 Million USD | 0.66% |
| 2024 Q4 | 423.54 Million USD | 0.5% |
| 2024 Q1 | 425.88 Million USD | 0.08% |
| 2024 Q3 | 421.44 Million USD | -1.69% |
| 2023 FY | 425.55 Million USD | 1.4% |
| 2023 Q1 | 419.35 Million USD | -0.07% |
| 2023 Q2 | 417.02 Million USD | -0.56% |
| 2023 Q3 | 421.01 Million USD | 0.96% |
| 2023 Q4 | 425.55 Million USD | 1.08% |
| 2022 Q4 | 419.66 Million USD | 0.44% |
| 2022 Q1 | 430.01 Million USD | 4.56% |
| 2022 Q2 | 424.5 Million USD | -1.28% |
| 2022 Q3 | 417.82 Million USD | -1.57% |
| 2022 FY | 419.66 Million USD | 2.04% |
| 2021 FY | 411.25 Million USD | -3.75% |
| 2021 Q1 | 397.27 Million USD | -7.03% |
| 2021 Q2 | 400.36 Million USD | 0.78% |
| 2021 Q3 | 408.27 Million USD | 1.98% |
| 2021 Q4 | 411.25 Million USD | 0.73% |
| 2020 Q4 | 427.29 Million USD | -0.66% |
| 2020 FY | 427.29 Million USD | 10.04% |
| 2020 Q1 | 422.77 Million USD | 8.88% |
| 2020 Q2 | 423.47 Million USD | 0.17% |
| 2020 Q3 | 430.11 Million USD | 1.57% |
| 2019 Q4 | 388.31 Million USD | 8.32% |
| 2019 Q1 | 322.02 Million USD | -2.44% |
| 2019 Q3 | 358.49 Million USD | 5.46% |
| 2019 Q2 | 339.92 Million USD | 5.56% |
| 2019 FY | 388.31 Million USD | 17.64% |
| 2018 Q2 | 364.82 Million USD | 5.65% |
| 2018 FY | 330.09 Million USD | -8.29% |
| 2018 Q4 | 330.09 Million USD | -3.63% |
| 2018 Q3 | 342.54 Million USD | -6.11% |
| 2018 Q1 | 345.3 Million USD | -4.06% |
| 2017 FY | 359.93 Million USD | -12.08% |
| 2017 Q4 | 359.93 Million USD | -3.09% |
| 2017 Q3 | 371.39 Million USD | 0.78% |
| 2017 Q1 | 369.36 Million USD | -9.77% |
| 2017 Q2 | 368.51 Million USD | -0.23% |
| 2016 Q1 | 394.28 Million USD | 0.02% |
| 2016 Q3 | 427.67 Million USD | 3.69% |
| 2016 Q4 | 409.37 Million USD | -4.28% |
| 2016 Q2 | 412.45 Million USD | 4.61% |
| 2016 FY | 409.37 Million USD | 3.85% |
| 2015 FY | 394.19 Million USD | -0.62% |
| 2015 Q4 | 394.19 Million USD | 1.81% |
| 2015 Q3 | 387.17 Million USD | -1.13% |
| 2015 Q2 | 391.61 Million USD | 3.29% |
| 2015 Q1 | 379.14 Million USD | -4.41% |
| 2014 Q1 | 378.49 Million USD | 2.55% |
| 2014 Q4 | 396.64 Million USD | 0.35% |
| 2014 Q2 | 390.02 Million USD | 3.05% |
| 2014 Q3 | 395.24 Million USD | 1.34% |
| 2014 FY | 396.64 Million USD | 7.46% |
| 2013 Q2 | 264.8 Million USD | -1.53% |
| 2013 Q3 | 375.03 Million USD | 41.62% |
| 2013 Q4 | 369.09 Million USD | -1.58% |
| 2013 FY | 369.09 Million USD | 37.06% |
| 2013 Q1 | 268.92 Million USD | -0.14% |
| 2012 Q3 | 276.02 Million USD | 5.93% |
| 2012 Q4 | 269.3 Million USD | -2.44% |
| 2012 FY | 269.3 Million USD | 24.99% |
| 2012 Q1 | 261.01 Million USD | 21.14% |
| 2012 Q2 | 260.58 Million USD | -0.17% |
| 2011 FY | 215.45 Million USD | 131.41% |
| 2011 Q4 | 215.45 Million USD | 161.29% |
| 2011 Q3 | 82.45 Million USD | 4.6% |
| 2011 Q2 | 78.82 Million USD | -7.13% |
| 2011 Q1 | 84.88 Million USD | -8.83% |
| 2010 Q1 | 102.75 Million USD | -14.71% |
| 2010 Q2 | 103.11 Million USD | 0.34% |
| 2010 Q3 | 96.28 Million USD | -6.62% |
| 2010 Q4 | 93.1 Million USD | -3.3% |
| 2010 FY | 93.1 Million USD | -22.72% |
| 2009 Q2 | 142.94 Million USD | -4.45% |
| 2009 Q4 | 120.48 Million USD | -3.56% |
| 2009 Q3 | 124.93 Million USD | -12.6% |
| 2009 FY | 120.48 Million USD | -26.64% |
| 2009 Q1 | 149.59 Million USD | -8.92% |
| 2008 Q2 | 170.12 Million USD | -9.04% |
| 2008 Q1 | 187.04 Million USD | -9.49% |
| 2008 Q4 | 164.24 Million USD | -1.65% |
| 2008 FY | 164.24 Million USD | -20.53% |
| 2008 Q3 | 166.99 Million USD | -1.84% |
| 2007 Q4 | 206.66 Million USD | 2.72% |
| 2007 Q3 | 201.19 Million USD | -10.91% |
| 2007 FY | 206.66 Million USD | -5.84% |
| 2007 Q1 | 220.99 Million USD | 0.69% |
| 2007 Q2 | 225.84 Million USD | 2.19% |
| 2006 FY | 219.47 Million USD | 53.45% |
| 2006 Q4 | 219.47 Million USD | 0.0% |
| 2005 FY | 143.03 Million USD | 0.0% |
| 2005 Q4 | 143.03 Million USD | 0.0% |
| 2003 FY | 65.39 Million USD | 83.92% |
| 2002 FY | 35.55 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Envoy Medical, Inc. | 9.4 Million USD | -4404.818% |
| Delcath Systems, Inc. | 22.83 Million USD | -1754.716% |
| Xylo Technologies Ltd. | 31.46 Million USD | -1246.248% |